NEWRON PHARMACEUT. EO-20 Net Asset Quality Index
NEWRON PHARMACEUT. EO-20 net asset quality index. NEWRON PHARMACEUT. EO-20 (NP5) has a Net Asset Quality Index of -27.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €40.03 Million minus total liabilities of €51.15 Million yields net assets of €-11.13 Million. A higher index indicates a stronger, lower-leverage balance sheet. See NP5 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of NEWRON PHARMACEUT. EO-20 (2005–2025)
Net asset quality index of NEWRON PHARMACEUT. EO-20 from 2005 to 2025. This chart shows how NEWRON PHARMACEUT. EO-20's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the index stands at -27.8%, representing net assets of €-11.13 Million against total assets of €40.03 Million EUR. Check NP5 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
NEWRON PHARMACEUT. EO-20 Net Asset Quality Index by Year (2005–2025)
NEWRON PHARMACEUT. EO-20 net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for NEWRON PHARMACEUT. EO-20 from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of NEWRON PHARMACEUT. EO-20.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -27.8% | €-11.13 Million | €40.03 Million | €51.15 Million | ▼ -30.1 pp |
| 2024 | 2.3% | €1.46 Million | €63.91 Million | €62.45 Million | ▲ +117.9 pp |
| 2023 | -115.6% | €-29.91 Million | €25.87 Million | €55.77 Million | ▼ -77.9 pp |
| 2022 | -37.7% | €-14.03 Million | €37.20 Million | €51.23 Million | ▼ -43.9 pp |
| 2021 | 6.2% | €3.11 Million | €50.49 Million | €47.38 Million | ▼ -27.5 pp |
| 2020 | 33.7% | €17.25 Million | €51.20 Million | €33.95 Million | ▼ -27.4 pp |
| 2019 | 61.0% | €36.80 Million | €60.29 Million | €23.49 Million | ▼ -30.4 pp |
| 2018 | 91.4% | €54.84 Million | €60.00 Million | €5.16 Million | ▼ -1.3 pp |
| 2017 | 92.7% | €67.72 Million | €73.02 Million | €5.30 Million | ▲ +4.8 pp |
| 2016 | 87.9% | €49.75 Million | €56.59 Million | €6.84 Million | ▲ +4.3 pp |
| 2015 | 83.6% | €37.11 Million | €44.38 Million | €7.27 Million | ▲ +4.7 pp |
| 2014 | 78.9% | €29.26 Million | €37.07 Million | €7.81 Million | ▲ +12.2 pp |
| 2013 | 66.7% | €21.09 Million | €31.62 Million | €10.53 Million | ▲ +4.9 pp |
| 2012 | 61.8% | €27.61 Million | €44.65 Million | €17.04 Million | ▲ +13.3 pp |
| 2011 | 48.5% | €6.58 Million | €13.57 Million | €6.98 Million | ▼ -15.2 pp |
| 2010 | 63.7% | €12.19 Million | €19.13 Million | €6.94 Million | ▼ -6.5 pp |
| 2009 | 70.3% | €29.28 Million | €41.68 Million | €12.39 Million | ▼ -5.4 pp |
| 2008 | 75.7% | €45.81 Million | €60.54 Million | €14.73 Million | ▼ -5.9 pp |
| 2007 | 81.6% | €57.40 Million | €70.37 Million | €12.97 Million | ▲ +2.8 pp |
| 2006 | 78.8% | €67.86 Million | €86.16 Million | €18.30 Million | ▲ +6.3 pp |
| 2005 | 72.4% | €17.02 Million | €23.50 Million | €6.48 Million | — |